Introduction
The diuretic and natriuretic actions of frusemide are antagonized by concurrent treatment with aspirin1'2 and indomethacin. 3 Flupirtine is a new non-narcotic analgesic which is thought to act centrally rather than peripherally,4 and because it may be given to patients requiring treatment with frusemide it is important to know if it influences frusemide-induced diuresis.
Methods
The study was double-blind, randomized and placebo controlled, using a three-way cross-over comparison of three treatments in 12 healthy volunteers (5 male), aged [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] years, weight 41-82 kg. Written consent was given and the protocol was approved by the local ethics committee.
Volunteers were instructed that no alcoholic drinks should be taken for 24 hours before, and during each study day. No beverages containing caffeine were taken from the evening before until the end of each study day, and smoking was prohibited on the study days. Medication containing aspirin was avoided for one week before each study day.
The following oral treatments were given at 08.00 h after a light breakfast on three separate occasions at least one week apart; flupirtine maleate 200 mg, indomethacin 50 mg, and placebo. A double-dummy technique was used to conceal the identity of the treatments. One hour after each treatment, frusemide 20 mg orally was given. All treatments were taken with 100 ml water. Following administration of frusemide, 100 ml water was given hourly for 6 hours.
Volunteers emptied their bladders before receiving the test treatments and hourly total urine collections were made up to 6 h after the dose of frusemide. Urine volumes were recorded and 10ml aliquots stored at -20'C until analysis.
Urinary sodium and potassium concentrations were analysed by automated flame photometry (IL 943, Instrument Laboratory (UK) Ltd). The instrument was calibrated using a standard containing 100 mmol/l of both sodium and potassium. The calibration was checked and the instrument recalibrated automatically every 16 samples. Coefficients of variation were 1.2% and 0.9% for sodium and potassium respectively.
An independent running quality sample was arranged every 7 Table I .
Mean values for urinary volume, sodium and potassium excretion associated with the three treatments are shown in Figure 1 . 
